NIH-funded research NIH-funded research

Data tools to expand addiction services and reduce overdoses in Oregon

Official title: Supporting data-driven decision-making to support substance use service expansion policies and to prevent overdoses

Funded at Chestnut Health Systems, INC. · NIH-11192940 · Data updated 2026-11-12

This project creates easy-to-use data tools for community leaders and health programs so Oregon can expand addiction services and prevent overdoses.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionChestnut Health Systems, INC.
NIH-funded
Lab location1 site (Bloomington, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2025
Award (this year)$1,018,107
NIH project number5R33DA059163-03
Project IDNIH-11192940 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are people in Oregon affected by opioid or methamphetamine use, local service providers, and community leaders willing to share information and join co-design sessions.

Less likely to help

People living outside Oregon or those not connected to the programs targeted by Measure 110 are unlikely to see direct benefits from this work.

What this research studies

If you or your community are affected by opioid or methamphetamine use, this work brings together health, justice, and community groups to share practical data about service gaps and overdoses. Researchers will run collaborative "Discovery and Design" sessions with people who use services, providers, and policymakers to build dashboards and reports that answer real local questions. The team will pilot those tools during the rollout of Oregon's Measure 110 funding to see how they help guide decisions on where to place services. The aim is to make it easier for counties and service agencies to target treatment, harm reduction, and prevention where they are needed most.

Why it matters

Potential benefit: If successful, communities could use clearer data to direct funding and create more treatment and overdose-prevention services where they're most needed.

How similar studies have gone: Some local data-sharing initiatives have improved service planning, but combining statewide Measure 110 rollout with structured co-design sessions is relatively new.

Where this research is happening

  • Chestnut Health Systems, INC.
    Bloomington, United States
    Active

Researchers

  • Principal investigator: Cruden, Gracelyn — Chestnut Health Systems, INC.
  • Study coordinator: Cruden, Gracelyn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.